According to our algorithm, we performed only ARSA gene sequencing in patients testing positive to the second-line test, as the IRB that approved this study considered as inappropriate the inclusion of genetic investigation of prosaposin B deficiency or MSD. This evidence concerns the gene ARSA and hyperinsulinemic hypoglycemia, familial, 4.